Prescription Drugs

Department of Health written question – answered on 8th December 2014.

Alert me about debates like this

Photo of George Howarth George Howarth Labour, Knowsley

To ask the Secretary of State for Health, what discussions he has had with (a) NHS England, (b) the Medicines and Healthcare Products Regulatory Agency, (c) patient groups and (d) professional groups about prescribing drugs for licensed and off-label indications.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

In developing our response to the Off-patent Drugs Bill, we have taken advice from clinicians and officials at NHS England, the National Institute for Health and Care Excellence and the Medicines and Healthcare products Regulatory Agency, and taken account of views expressed by other stakeholder organisations. Officials have also had discussions with Breast Cancer Campaign to understand their concerns around the prescribing of off-patent drugs and the implications for patients.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.